Beauty Health Past Earnings Performance
Past criteria checks 0/6
Beauty Health has been growing earnings at an average annual rate of 6.5%, while the Personal Products industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 19.8% per year.
Key information
6.5%
Earnings growth rate
23.0%
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | 19.8% |
| Return on equity | -121.0% |
| Net Margin | -22.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump
Aug 06
Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?
Jul 16Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%
Jun 14Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)
May 30The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company
Feb 16The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion
Jun 19Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?
May 28At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?
Apr 04Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality
Mar 08What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?
Jan 01An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued
Dec 05The Beauty Health Company: A Compelling Mid To Long-Term Growth Story
Oct 12Beauty-Health Company announces $200M buyback program
Sep 27The Beauty Health Q2 2022 Earnings Preview
Aug 08The Beauty Health Company: Not Looking The Best
Jul 30Beauty Health: Skincare Today And Alpha Tomorrow
May 13Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates
May 12Revenue & Expenses Breakdown
How Beauty Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 366 | -84 | 253 | 9 |
| 31 Mar 24 | 393 | -81 | 269 | 11 |
| 31 Dec 23 | 398 | -100 | 276 | 10 |
| 30 Sep 23 | 399 | -84 | 282 | 9 |
| 30 Jun 23 | 391 | -10 | 278 | 9 |
| 31 Mar 23 | 377 | -7 | 273 | 9 |
| 31 Dec 22 | 366 | 44 | 266 | 8 |
| 30 Sep 22 | 346 | 20 | 261 | 9 |
| 30 Jun 22 | 325 | -195 | 247 | 9 |
| 31 Mar 22 | 288 | -340 | 245 | 9 |
| 31 Dec 21 | 260 | -379 | 210 | 8 |
| 30 Sep 21 | 220 | -365 | 175 | 7 |
| 30 Jun 21 | 186 | -152 | 143 | 6 |
| 31 Mar 21 | 134 | -23 | 84 | 3 |
| 31 Dec 20 | 119 | -29 | 81 | 3 |
| 30 Sep 20 | 131 | -19 | 77 | 4 |
| 31 Dec 19 | 167 | -2 | 88 | 5 |
| 31 Dec 18 | 112 | -91 | 61 | 2 |
Quality Earnings: SKIN is currently unprofitable.
Growing Profit Margin: SKIN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SKIN is unprofitable, but has reduced losses over the past 5 years at a rate of 6.5% per year.
Accelerating Growth: Unable to compare SKIN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SKIN is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (15.6%).
Return on Equity
High ROE: SKIN has a negative Return on Equity (-120.97%), as it is currently unprofitable.